J. K. Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -4.81%
- Profit Growth -34.63%
- Ebitda 39.01%
- Net Worth 7.01%
- Total Assets -22.27%
About J. K. Lifescience
J. K. Lifescience Private Limited (JKLPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 June 2009 and has a history of 15 years and seven months. Its registered office is in Dadra & Nagar Haveli, Dadra & Nagar Haveli, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmeshkumar Chauhan and Nimishaben Chauhan serve as directors at the Company.
Company Details
- Location
Dadra & Nagar Haveli, Dadra & Nagar Haveli, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24294DN2009PTC000298
- Company No.
000298
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at J. K. Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmeshkumar Chauhan  | Director | 25-Jun-2009 | Current |
| Nimishaben Chauhan | Director | 25-Jun-2009 | Current |
Financial Performance of J. K. Lifescience.
J. K. Lifescience Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.81% decrease. The company also saw a substantial fall in profitability, with a 34.63% decrease in profit. The company's net worth moved up by a moderate rise of 7.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J. K. Lifescience?
In 2022, J. K. Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dharmaadaahi FoundationDharmeshkumar Chauhan and Nimishaben Chauhan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at J. K. Lifescience?
Unlock and access historical data on people associated with J. K. Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. K. Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. K. Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.